Among the primary reasons for low influenza immunization rates are missed opportunities. [1] [2] [3] 5 Of those who die of influenza, 75% to 90% had visited a physician as an outpatient in the year before their death, but were not vaccinated [5] [6] [7] [8] Year after year, at least 30 million American adults continue to be inadequately vaccinated and are vulnerable to influenza. 1, 4 Pharmacists are regarded as trusted health professionals, 9 readily accessible to the public even in rural zip codes and health professional shortage areas. 10 Since the mid-1990s, progressively more pharmacists have become vaccine advocates and providers. 11-14 Many people at risk of influenza have chronic diseases, 2-4 for which they receive prescription medications dispensed by pharmacists. 15 Pharmacists can identify adults who should be immunized [15] [16] [17] [18] [19] [20] and persuade them to be immunized. [15] [16] [20] [21] Research shows a willingness on the part of adults to be immunized in a pharmacy by a pharmacist. 13 , 21 It has not been previously established whether vaccine administration by pharmacists increases immunization among adult prescription recipients or whether pharmacy-based programs merely displace these adults from being immunized by other providers. This study was designed to answer that question, evaluating how a new type of vaccine provider affects adult vaccine delivery. Given pharmacists' knowledge of patients' underlying illnesses, we assessed the hypothesis that more convenient access to vaccination by community pharmacists (based on proximity and hours of availability) will be associated with net increases in immunization rates.
Washington is 1 of 32 States where state regulations explicitly authorize pharmacists to administer medications. In contrast, Oregon regulations did not explicitly authorize drug administration by pharmacists at the time of this study, nor were any pharmacists known to do so. Nonetheless, Oregon and Washington had comparable adult immunization programs and levels in 1995, based on Medicare reimbursement claims (48% vs. 47% vaccinated, respectively) or the Behavioral Risk Factor Surveillance Summary (66% vs. 67%). 22 
Characteristics of Study Subjects
The cohorts of eligible Washington and Oregon subjects did not differ on the basis of age, number of prescription fills, or health conditions for which they took prescription medications. The US Postal Service returned 412 surveys as undeliverable; 22 survey responses were uninterpretable. Among the 3,991 potential respondents, 2,090 usable surveys were completed and returned (52%). The response rate was 51% for the Washington cohort and 55% for the Oregon cohort.
The 2,090 people who responded with usable surveys did not differ from the remaining 2,313 nonrespondents on the basis of gender, number of prescription fills, cardiovascular medications, or multiple diagnostic indications (Table 2) . Subjects in Washington, people younger than 65 years of age, and people taking indicator medications, respiratory medications, or hypoglycemic medications were less likely than their counterparts to Distribution of subjects who reported being vaccinated against influenza in 1997 or 1998 appear in Table 3 and Table 4 . The net difference between states in proportions vaccinated among respondents 65 years or older was + 4.7% (95% CI: -4.5%, + 14.1%), and + 10.6% among younger respondents taking indicator medications (95% CI: 0.0%, + 21.2%).
The association for each risk-based stratum was also assessed by nonparametric methods, using Wilcoxon's rank sum test, to analyze the findings according to the sampling unit (each pharmacy). For respondents 65 years or older, the increased proportion vaccinated in Washington did not reach statistical significance (P = 0.11). For respondents younger than 65 years of age taking indicator medications, the difference between state cohorts for vaccination in 1998 was nearly significant (P = 0.054).
In addition to overall trends, we considered vaccine-seeking behavior at the individual level. Table 5 depicts the vaccination behavior of 1,161 subjects who reported where they were vaccinated against influenza in both 1997 and 1998: 73% were vaccinated by a traditional provider in both years, 89% were vaccinated by the same category of vaccine provider in both years. McNemar's test statistic indicates that the provider distribution in 1998 did not differ significantly from that in 1997 (ie, 5% -6.5%, P = 0.15).
These data can also be assessed as 2 cohorts, distinguished by type of vaccine provider in 1997. This allows a chi-squared test to determine if the conditional probability of going to a nontraditional provider in 1998 given a traditional provider in 1997 differs from the opposite case, the probability of going to a traditional provider in 1998 given a nontraditional provider in 1997. The data in Table  5 show that people who used a traditional provider in 1997 were more likely to return to that provider category in 1998 than were people to visit a nontraditional provider in both 1997 and 1998 (24.8% vs. 8.1%, P <0.0001). Applying McNemar's and chi-squared tests to data from Washington only, comparable results obtained.
Between 1997 and 1998, respondents in Washington younger than 65 years taking indicator medications who reported receiving influenza vaccination from pharmacists increased 8 percentage points, from 9% to 17% (P = 0.002), with a proportional decrease in nonvaccinated people, from 43% to 34% (Figure 1) Among the respondents, 595 reported being vaccinated against influenza in 1998, but not in 1997 (Table 4) . Overall, 10.8% more respondents from Washington were vaccinated than their Oregon counterparts (95% CI: 3.5%, 18.1%). The increased likelihood holds for both strata. For respondents 65 years or older, the difference in proportion vaccinated was 13.8% (95% CI: 2.6%, 25.0%). Among younger adult respondents taking indicator medications, the difference in proportion vaccinated was 9.6% (95% CI: 0.04%, 19.3%).
The overall association was also assessed by nonparametric methods, using Wilcoxon's rank sum test, to analyze the findings according to the sampling unit (each pharmacy). The difference between state cohorts for people unvaccinated in 1997 was statistically significant by this test, as well (P = 0.03). was larger than expected by chance (P = 0.02). The rate ratio was 2.1 (95% CI: 1.1, 3.9). People vaccinated in physician offices in 1997 were more likely to return to physician offices for vaccination in 1998 than for people vaccinated elsewhere in 1997 to again be vaccinated outside a physician office in 1998 (29.2% vs. 12.1%, P <0.0001).
Discussion
Vaccine delivery by pharmacists was associated with a 10.6% higher influenza vaccination rate among respondents younger than 65 who took medications for prolonged conditions (Table 3) . Vaccine delivery by pharmacists was also associated with a 10.8% higher influenza vaccination rate among adult prescription recipients unvaccinated against influenza in the previous year (Table 4) .
Influenza vaccination rates for prescription recipients 65 years and older increased only slightly in Washington ( than for people vaccinated in nontraditional settings to continue that pattern (Table 5) . Table 1 was 91% for the previous year when validated by record review.25 Among elderly managed-care patients in an outpatient setting, self-report of influenza vaccine in the previous year had a sensitivity of 98% and a specificity of 71%. 26 Despite asking about managed-care status and other forms of insurance coverage in these surveys, we were not able to assess insurance coverage with sufficient reliability to address any role it may have played. To be eligible for our study, subjects had to receive prescriptions at these pharmacies, without regard to insurance status. We consider it unlikely that managed-care status would increase choice of pharmacists as vaccine providers.
If nonrespondents to the survey were less likely to have been immunized than respondents, then observed immunization rates might overestimate actual rates. Such an error may be nondifferential between the intervention and control groups, biasing toward the null. Response bias of this type was not observed in a Durham County, NC, study of vaccination among prescription recipients.20 '27 The The major advantage of this study is its assessment of typical vaccination practices, rather than a contrived experiment. This study is one of few to report vaccine-acceptance rates among people younger than age 65 with extensive health conditions. Previous studies found influenza vaccine coverage levels of 14% to 39% among adults in high-risk populations younger than age 65.4, 28 This study found 58% to 66% coverage. This study's design and setting poses a difficult test of the effect of pharmacists as immunizers. The communities studied had many sources of vaccine delivery and extensive networks of health insurance. Further, all prescription recipients, by definition, have access to other professionals capable of providing vaccines, their physicians. Nonetheless, this study found that more people were vaccinated in settings where pharmacists vaccinate than in settings where pharmacists did not vaccinate. Whether these findings would apply among people who do not routinely see a physician cannot be determined from this study. Effects of pharmacist-immunizers in other settings with fewer options for vaccine delivery may be different, perhaps greater.
Assuring immunization of the large and growing population of people of advancing age or with chronic disease at high-risk of lethal infection is a continuing challenge for the health-care system. Increasing vaccination in the community could help in reaching the Healthy People 2010 goal of 90% vaccination of people 65 years and older in the United States. Since this study was conducted, the US Advisory Committee on Immunization Practices (ACIP) strongly encouraged standing orders to increase adult vaccination against influenza and pneumococcal disease.14 The ACIP recommendations encompass long-term care facilities, inpatient and outpatient facilities, pharmacies, adult workplaces, and home health agencies: "Because of the societal burden of influenza and pneumococcal disease, implementation of standing orders program to improve adult vaccination coverage for these diseases should be a national public health priority." Our study indicates that pharmacy-based immunization programs can contribute to a net increase in delivery of influenza vaccine, without disrupting the balance in immunization delivery between traditional and nontraditional sites.
